Time to talk.
UK life and health insurers have found themselves under attack over their use of genetic test results. The Association of British Insurers' response of a five-year moratorium could be good news, reports Keith Sankey.
View the pdf of this story
The use of genetic testing to diagnose and predict the future development and progress of disease is a highly controversial topic in the UK life and health insurance market
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Regulation
Why Which?’s super-complaint is a turning point for insurance
Rocio Concha, director of policy and advocacy at Which?, explains why the Financial Conduct Authority’s agreement with its super-complaint marks a critical moment for home and travel insurance, and why swift regulatory action is now essential to improve consumer outcomes.
Axa Partners hit with FCA limitations
Following the Which? super complaint, the Financial Conduct Authority has told Axa Partners UK it cannot grow its current customer base without written permission from the regulator.
FCA partly rebuffs Which? but widens insurance crackdown
The Financial Conduct Authority has pushed back against parts of Which?’s super complaint about home and travel insurance, but accepted there are clear weaknesses in the market that require further regulatory action.
Motor Insurance Taskforce report proves providers call the shots
Deputy Editor’s View: Scott McGee observes the Labour government’s motor insurance taskforce report felt more like a victory for industry lobbying than for politicians or drivers.
FCA tries to clarify bullying and harassment standards for insurers
The Financial Conduct Authority has issued final guidance setting out how insurers must address bullying, harassment and violence, after 95% of consultation respondents called for further clarification.
Government admits motor taskforce suggestions ‘unlikely to reduce premiums’
The findings of the government’s Motor Insurance Taskforce have been published today (10 December), outlining its suggestions on how to bring motor premiums down.
FCA trims insurance rules but pace criticised by market
The Financial Conduct Authority today (9 December) confirmed plans to simplify its insurance rules, but industry reaction suggests the changes don’t go far or fast enough.
ABI says Which?’s complaint evidence ‘doesn’t reflect reality’
Trade Voice: Chris Bose, director of general insurance and international at the Association of British Insurers, responds to concerns raised by Which? and sets out why practical, proportionate reforms are essential to strengthen trust in the market.